Geisinger and Merck & Co. have developed two EHR based programs named MedTrue and the Family Caregiver to improve adherence to medications, help providers and patient care and reduce drug errors. As these two apps are entering into market they have become a popular discussion topic with a few health IT companies.
Blockchain technologies have devised a method to obtain a patient’s health records from a blockchain database even if they are unable to communicate. A verification from two different keys is needed for this step.
There are three instances of Epic along with three varied versions of Meditech, Athena health and Cerner. Lahey Health, Beth Israel Deaconess Medical Center along with three other hospitals, are currently involved in merging the organizations under one roof, as they are operating with varied EHR vendors and versions.
Following a successful nine-month pilot, Boehringer Ingelheim and HealthPrize Technologies announced that the digital adherence support program RespiPoints will be expanded to any patient who is taking certain Boehringer Ingelheim medications, including some available in the Respimat inhaler.
Boehringer Ingelheim, headquartered in Ingelheim, Germany, and OSE Immunotherapeutics, based in Nantes, Frances, signed a collaboration and license deal to jointly develop OSE-172 for myeloid cancers.
Such alerts remind clinicians about everything from a patient's drug allergies, to possible drug interactions, to dosing guidelines, to lab testing guidance. Clinicians can either follow the alerts' recommendations, override them, or ignore them.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.